
Welcome ACR Attendees: Safeguarding Per Protocol Integrity in Complex Rheumatology Trials
Connecting more than 30 years of clinical trial data management with specialized, platform-driven eligibility verification and endpoint adjudication.
Precision Data Governance Before First Dose
In autoimmune and rheumatology clinical trials, isolating a clear therapeutic signal demands adherence to protocol entry criteria and continuous protocol compliance. Published literature reports that 10% to 40% of enrolled subjects fail full inclusion or exclusion compliance across clinical trials. In complex lupus studies, centralized review is critical to success.
Prospective Pre-Randomization Review
WebFXP & WebEAS
Intercept eligibility variances in real time during the active screening period.
- Three Review Models: Flexible deployment for IC/EX checklist verification, source document corroboration, or full diagnostic validation.
- Automated Gating: Randomization credentials remain locked until centralized clinical clearance is granted.
- Documented Protection: In documented trial data, central prospective review identified 129 ineligible candidates out of 438 site-approved submissions. In that trial, 100% of enrolled subjects were evaluable for the per protocol analysis, helping protect the study’s statistical power.
Flare & Treatment Failure Adjudication
WebEAS
Maintain objective endpoint oversight across longitudinal autoimmune evaluations.
- Role-Based Workflow Automation: Directs clinical event dossiers to qualified medical specialists based on predefined stopping parameters.
- Native Source Redaction: Secure processing and de-identification of clinic records, biomarker panels, and imaging series.
- Defensible Decision Records: Multi-reviewer parallel assessments, automated tie-breaking logic, and 21 CFR Part 11 compliant audit histories.
Centralized Monitoring & Oversight
Real-Time Protocol Transparency
Unify trial governance across distributed global investigator networks.
- Configurable Dashboards: Instant operational metrics covering screening velocity, query cycles, and reviewer response times.
- Reduced Site Friction: 86% of participating trial centers report our digital verification path is far superior to ad hoc paper routines.
- Human-in-the-Loop Governance: Balanced operational architecture pairing automated tracking with accountable expert clinical review.
Connect with Our Team at ACR Convergence
Schedule a focused, 20-minute discussion in Orlando to evaluate your study eligibility architecture, flare adjudication workflows, or centralized monitoring systems.
Location: Orange County Convention Center / Meeting Lounges, Orlando, FL
Dates: November 6 through November 11, 2026
Focus Topics: Centralized Pre-Randomization Review, Flare Adjudication Panels, Reducing Site Screen Failure Overhead
Send the form and someone from our team will email you to set a time in Orlando.
Capabilities overview
Download the CISYS Capabilities Overview
Adaptive Clinical Infrastructure
Two pages on how CISYS works with study teams: the five Sequence Platform modules, how custom configurations get validated, and what happens between protocol review and database lock.
